Methylene Blue
Thiazine dye with mitochondrial-electron-shuttle activity. Approved for methemoglobinemia; off-label low-dose oral use for cognition.
At a glance
- Common vial size
- Not vial-based
- Reference dose
- 15 mg
- Frequency
- Once daily, oral
Reference titration protocol
Oral 15–30 mg/day; low-dose hormetic window. Avoid serotonergics, G6PD CI.
| Step | Dose | Duration | Administrations / week |
|---|---|---|---|
| 1 | 15 mg | 4 weeks | 7× |
Clinical notes
- Serotonin-syndrome risk with SSRIs/MAOIs
- Stains urine and mucosa blue
Available formulations
Presentations carried across the VitaRelay pharmacy network, including 503A compounded, 503B outsourcing facility, and research & development sourcing. Pricing and state-level availability are shown to verified accounts only.
- 10 ml · Injectable503B
- Capsule/TabletRUO
- Capsule/Tablet503A
References
Often used with
Compounds commonly discussed alongside Methylene Blue in published protocols and prescriber requests. Listed for reference only — not a clinical recommendation, and not a suggestion to co-administer.
Pricing and ordering are for verified accounts
VitaRelay serves licensed practices, prescribers, and pharmacies. Catalog pricing, availability by state, and ordering are available after your account is verified.
